18:16:02 EST Wed 11 Dec 2024
Enter Symbol
or Name
USA
CA



Diagnos Inc (3)
Symbol ADK
Shares Issued 89,918,940
Close 2024-10-17 C$ 0.335
Market Cap C$ 30,122,845
Recent Sedar Documents

Diagnos hires Red Cloud for market-making services

2024-10-17 17:45 ET - News Release

Mr. André Larente reports

DIAGNOS ANNOUNCES THE ENGAGEMENT OF MARKET MAKER CONSULTANT

Diagnos Inc. has engaged Red Cloud Securities Inc. to provide market-making services to the corporation.

As per the agreement signed between Red Cloud and Diagnos, Red Cloud is entitled to a monthly flat fee of $7,000, payable quarterly in advance in cash, for the period of Oct. 17, 2024, to Oct. 16, 2026. During the period, either party may terminate the agreement with a 30-day notice to the other party.

As part of the services to be rendered to the corporation, Red Cloud undertakes to use its best efforts to (i) maintain a reasonable and consistent bid and offer spread for the corporation's common stocks and (ii) supply liquidity using its own cash in hand. The services will mainly be rendered by Adam Smith who is acting at arm's length to the corporation. As of the date of this announcement, Red Cloud, together with Mr. Smith, own securities of the corporation in the form of common shares and shares warrants.

The engagement of Red Cloud remains subject to the acceptance of the TSX Venture Exchange.

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its Flaire artificial intelligence (AI) platform. Flaire allows for quick modifying and developing of applications such as CARA (computer-assisted retina analysis). CARA's image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.